Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 26-Jul-24 9:22 PM View:  | Novo A/s 10% Owner | Io Biotech, Inc. (IOBT) | 26-Jul-24 | Sale | 23,478 | $1.31 | $30,786.70 | (< 1%) 4.38M to 4.35M | |
| 26-Jul-24 9:22 PM View: | Novo A/s 10% Owner | Io Biotech, Inc. (IOBT) | 25-Jul-24 | Sale | 51,522 | $1.33 | $68,338.80 | (1%) 4.43M to 4.38M | |
| 14-May-24 9:13 PM View: | Novo A/s 10% Owner | Io Biotech, Inc. (IOBT) | 10-May-24 | Sale | 658,809 | $1.22 | $802,495.00 | (13%) 5.09M to 4.43M | |
| 13-Feb-24 9:31 PM View: | Novo A/s 10% Owner | Io Biotech, Inc. (IOBT) | 09-Feb-24 | Sale | 658,809 | $1.50 | $988,411.00 | (11%) 5.75M to 5.09M | |
| 24-Nov-23 5:37 PM View: | Burkavage Brian Chief Accounting Officer | Io Biotech, Inc. (IOBT) | 22-Nov-23 | Purchase | 5,000 | $1.03 | $5,175.00 | 77% 6.5K to 11.5K | |
| 24-Nov-23 5:37 PM View: | Burkavage Brian Chief Accounting Officer | Io Biotech, Inc. (IOBT) | 21-Nov-23 | Private Purchase | 5,000 | $0.99 | $4,950.00 | 333% 1.5K to 6.5K | |
| 09-Aug-23 8:41 PM View: | Sullivan Amy Chief Financial Officer | Io Biotech, Inc. (IOBT) | 09-Aug-23 | Grant | 49,382 | $1.90 | $93,825.80 | 198% 25.0K to 74.38K | |
| 11-Aug-23 9:24 PM View: | Elling Christian E Director 10% Owner | Io Biotech, Inc. (IOBT) | 09-Aug-23 | Grant Duplicate | 7,901,230 | $1.90 | $15,012,300.00 | 131% 6.05M to 13.95M | |
| 09-Aug-23 8:43 PM View: | Zocca Mai-Britt Chief Executive Officer Director | Io Biotech, Inc. (IOBT) | 09-Aug-23 | Grant | 37,037 | $1.90 | $70,370.30 | 138% 26.93K to 63.97K | |
| 10-Aug-23 9:03 AM View: | Vivo Capital Ix, LLC 10% Owner | Io Biotech, Inc. (IOBT) | 09-Aug-23 | Private Purchase | 3,157,890 | $1.90 | $6,000,000.00 | 105% 3.02M to 6.17M | |
| 09-Aug-23 8:38 PM View: | Smith Devin Whittemore General Counsel | Io Biotech, Inc. (IOBT) | 09-Aug-23 | Grant | 4,938 | $1.90 | $9,382.20 | 100% 0 to 4.94K | |
| 11-Aug-23 9:22 PM View: | Lundbeckfond Invest A/s Director 10% Owner | Io Biotech, Inc. (IOBT) | 09-Aug-23 | Grant | 7,901,230 | $1.90 | $15,012,300.00 | 131% 6.05M to 13.95M | |
| 11-Aug-23 4:31 PM View: | Novo A/s 10% Owner | Io Biotech, Inc. (IOBT) | 09-Aug-23 | Private Purchase | 2,469,140 | $2.03 | $5,000,000.00 | 76% 3.24M to 5.71M | |
| 20-Mar-23 5:35 PM View: | Sullivan Amy Chief Financial Officer | Io Biotech, Inc. (IOBT) | 17-Mar-23 | Private Purchase | 25,000 | $2.32 | $58,017.50 | 100% 0 to 25.0K | |
| 10-Nov-21 7:04 PM View: | Novo A/s 10% Owner | Io Biotech, Inc. (IOBT) | 09-Nov-21 | Market Purchase | 325,000 | $14.00 | $4,550,000.00 | 11% 2.95M to 3.28M | |
| 12-Nov-21 4:16 PM View: | Andersson Claus A. Director | Io Biotech, Inc. (IOBT) | 09-Nov-21 | Market Purchase | 75,000 | $14.00 | $1,050,000.00 | 4% 1.72M to 1.79M | |
| 12-Nov-21 4:16 PM View: | Hbm Bioventures Cayman Ltd 10% Owner | Io Biotech, Inc. (IOBT) | 09-Nov-21 | Market Purchase | 325,000 | $14.00 | $4,550,000.00 | 14% 2.37M to 2.69M | |
| 10-Nov-21 7:04 PM View: | Novo A/s 10% Owner | Io Biotech, Inc. (IOBT) | 09-Nov-21 | Conversion | 2,952,930 | -- | -- | 100% 0 to 2.95M | |
| 12-Nov-21 4:16 PM View: | Andersson Claus A. Director | Io Biotech, Inc. (IOBT) | 09-Nov-21 | Conversion | 1,716,490 | -- | -- | 100% 0 to 1.72M | |
| 12-Nov-21 4:16 PM View: | Hbm Bioventures Cayman Ltd 10% Owner | Io Biotech, Inc. (IOBT) | 09-Nov-21 | Conversion | 2,365,540 | -- | -- | 100% 0 to 2.37M | |
| 12-Nov-21 4:15 PM View: | Nielsen Jack Director | Io Biotech, Inc. (IOBT) | 09-Nov-21 | Market Purchase Duplicate | 650,000 | $14.00 | $9,100,000.00 | 27% 2.37M to 3.02M | |
| 12-Nov-21 4:16 PM View: | Vivo Capital Ix, LLC 10% Owner | Io Biotech, Inc. (IOBT) | 09-Nov-21 | Market Purchase | 650,000 | $14.00 | $9,100,000.00 | 27% 2.37M to 3.02M | |
| 12-Nov-21 4:15 PM View: | Nielsen Jack Director | Io Biotech, Inc. (IOBT) | 09-Nov-21 | Conversion Duplicate | 2,365,540 | -- | -- | 100% 0 to 2.37M | |
| 12-Nov-21 4:16 PM View: | Vivo Capital Ix, LLC 10% Owner | Io Biotech, Inc. (IOBT) | 09-Nov-21 | Conversion | 2,365,540 | -- | -- | 100% 0 to 2.37M | |
| 12-Nov-21 4:15 PM View: | Zocca Mai-Britt Chief Executive Officer Director | Io Biotech, Inc. (IOBT) | 09-Nov-21 | Conversion | 26,580 | -- | -- | 7508% 0.35K to 26.93K | |
| 12-Nov-21 4:15 PM View: | Lundbeckfond Invest A/s 10% Owner | Io Biotech, Inc. (IOBT) | 09-Nov-21 | Market Purchase | 2,142,860 | $14.00 | $30,000,000.00 | 55% 3.91M to 6.05M | |
| 12-Nov-21 4:16 PM View: | Malier Vanessa Director | Io Biotech, Inc. (IOBT) | 09-Nov-21 | Market Purchase Duplicate | 325,000 | $14.00 | $4,550,000.00 | 31% 1.06M to 1.39M | |
| 12-Nov-21 4:15 PM View: | Lundbeckfond Invest A/s 10% Owner | Io Biotech, Inc. (IOBT) | 09-Nov-21 | Conversion | 3,906,600 | -- | -- | 100% 0 to 3.91M | |
| 12-Nov-21 4:16 PM View: | Malier Vanessa Director | Io Biotech, Inc. (IOBT) | 09-Nov-21 | Conversion | 1,064,040 | -- | -- | 100% 0 to 1.06M |
